Navigation Links
FedCentric Technologies, LLC Begins Collaboration With Frederick National Laboratory for Cancer Research
Date:8/12/2015

FAIRFAX, Va., Aug. 12, 2015 /PRNewswire/ -- FedCentric Technologies and the Frederick National Laboratory for Cancer Research (FNLCR) have entered into a collaborative agreement to develop a High-Performance Data Analytics (HPDA) platform to provide bioinformaticians with new insights into the genetic roots of cancer. A rapidly emerging technology, HPDA combines high-performance computing with advanced data analytics.

FedCentric has assembled a team of mathematicians and computer scientists to work closely with Jack Collins, Ph.D., and his research team at FNLCR to extract knowledge and insights from large, complex genomic databases in an ongoing effort to improve cancer diagnostics and treatments.  According to FNLCR, the goal of these collaborative agreements is to "accelerate treatment for cancer by bridging the gap between late discovery and early development of diagnostics and therapeutics, developing cross-cutting technology platforms, and developing data standards."

"This is a great example of what's possible when academia, industry, and government collaborate.  We're very excited to be working with Dr. Collins' team, and we look forward to seeing fruitful progress in this important pilot," said Gerry Kolosvary, CEO of FedCentric Technologies.

FedCentric has already developed and implemented HPDA solutions as the prime contractor with the United States Postal Service to significantly improve its computer-based logistics. The Office of Science and Technology Policy at The White House recognized FedCentric for its groundbreaking development of HPDA solutions for the United States Postal Service.

The Frederick National Laboratory for Cancer Research is a Federally Funded Research and Development Center sponsored by the National Cancer Institute. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E.  The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.

FedCentric Technologies, LLC is responsible for the content of this announcement.

Contact:
Michael Atkins, PhD
Bioscience Advisor
8315 Lee Hwy, Suite 500
Fairfax, VA 22013
(301) 263-0030 ext. 528
michael.atkins@fedcentric.com

Logo - http://photos.prnewswire.com/prnh/20131003/PH91185LOGO


'/>"/>
SOURCE FedCentric Technologies, LLC
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc.
2. Harwood Feffer LLP Announces Investigation of Avalanche Biotechnologies, Inc.
3. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avalanche Biotechnologies, Inc. - AAVL
4. Global Proteomics Market 2015-2019 - Increase in Demand for Personalized Medicines with Agilent Technologies, Danaher & Thermo Fischer Scientific Dominating
5. Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024
6. Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies
7. Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024
8. Global Cell Therapy Market 2015-2020 - Technologies, Markets and Companies
9. Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies
10. Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer
11. Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2020)... ... 10, 2020 , ... Ortho Clinical Diagnostics, a global leader of in vitro ... Sera, ID-MTS, a suite of extended antigen in a gel testing format used for ... VISION® and ORTHO VISION® Max in the United States and Canada. The clearances allow ...
(Date:3/4/2020)... ... ... This month, Cognosante will make its annual appearance at the HIMSS Global Health ... offerings that align with the HIMSS annual theme, “Be the Change.” , Cognosante’s ... From Interoperability and HIE to Cloud Computing and ...
(Date:2/28/2020)... ... February 26, 2020 , ... Designed primarily for ... with a dedicated controller, thus simplifying setup, streamlining integration, and optimizing workflow. Capable ... first of Fastec Imaging’s new HS Series cameras to be released. The HS ...
(Date:2/21/2020)... (PRWEB) , ... February 20, 2020 , ... ... ensuring supply chain transparency and reassuring consumers that what’s listed on an ingredient ... trademarked ingredients, Nutrition21 has introduced this solution with the adoption of CertainT, which ...
Breaking Biology Technology:
(Date:3/11/2020)... (PRWEB) , ... March 11, 2020 , ... ... and telemedicine company backed by Siemens Healthineers and several healthcare VC firms introduces ... over 100,000 people in over 100 countries and has caused over 4,000 fatalities ...
(Date:3/5/2020)... ... March 05, 2020 , ... With ... agreement with Phoenestra GmbH to accelerate Cytonus’ existing products and to expand the ... California. Phoenestra is a biotech company located in Austria. , Phoenestra has ...
(Date:3/5/2020)... ... March 05, 2020 , ... In September 2016, ... The AlphaSTEM Test™ is the first, and still only, available technology that provides ... attempt to provide information about the number and quality of therapeutic tissue stem ...
Breaking Biology News(10 mins):